Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid PGT, Inc. (PGTI)?

Page 1 of 2

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track more than 700 prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile gigantic failures like hedge funds’ recent losses in Valeant. Let’s take a closer look at what the funds we track think about PGT, Inc. (NASDAQ:PGTI) in this article.

PGT, Inc. (NASDAQ:PGTI)’s stock is up year-to-date, but it lost 13% in the third quarter, which led to a weaker sentiment from smart money investors. At the end of this article we will also compare PGTI to other stocks, including Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Veritiv Corp (NYSE:VRTV), and Unisys Corporation (NYSE:UIS) to get a better sense of its popularity.

Follow Pgt Inc. (NASDAQ:PGTI)
Trade (NASDAQ:PGTI) Now!

In the 21st century investor’s toolkit there are a multitude of gauges stock traders can use to analyze publicly traded companies. Two of the best gauges are hedge fund and insider trading moves. Our researchers have shown that, historically, those who follow the best picks of the elite hedge fund managers can trounce the broader indices by a very impressive margin (see the details here).

Keeping this in mind, let’s analyze the new action encompassing PGT, Inc. (NASDAQ:PGTI).

How have hedgies been trading PGT, Inc. (NASDAQ:PGTI)?

At the Q3’s end, a total of 11 of the hedge funds tracked by Insider Monkey held long positions in this stock, a decline of 39% from the second quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of key hedge fund managers who were increasing their stakes considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Renaissance Technologies holds the most valuable position in PGT, Inc. (NASDAQ:PGTI). Renaissance Technologies has a $39.9 million position in the stock, comprising 0.1% of its 13F portfolio. The second most bullish fund manager is PAR Capital Management, led by Paul Reeder and Edward Shapiro, holding a $13.8 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Some other professional money managers with similar optimism include Chuck Royce’s Royce & Associates, Richard Driehaus’s Driehaus Capital and Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!